Home / Health / Baltimore's Opioid Fight: $427.5M Restitution Fuels Progress
Baltimore's Opioid Fight: $427.5M Restitution Fuels Progress
30 Jul
Summary
- Baltimore secured $427.5 million in restitution from opioid companies.
- Overdose fatalities saw a 22% decline due to funded initiatives.
- The city monitors grant agreements to ensure fund accountability.

Baltimore City leaders are diligently assessing the allocation of $427.5 million in restitution funds aimed at curbing the opioid epidemic. These funds, secured by the city in 2022 after pursuing legal action against responsible companies, are being channeled into evidence-based initiatives.
Preliminary data indicates a significant 22% decrease in overdose fatalities within the city. Sara Whaley, executive director of the Mayor's Office of Overdose Reduction, attributes this progress, in part, to the Opioid Restitution Fund supporting crucial services. These include distributing naloxone, increasing access to medications for opioid use disorder, and providing test strips for substances like fentanyl and xylazine.
The city has established a rigorous grant monitoring process to ensure every dollar is accounted for and directed towards community needs. Currently, 31 agreements are in place, with substantial amounts committed and disbursed. While these restitution funds are finite, Baltimore is focused on strengthening programs to make them competitive for future funding sources, ensuring a sustained effort against the ongoing crisis.